About Us

As a globally operating Contract Development and Manufacturing Organisation (CDMO) headquartered in Munich, Germany, we are dedicated to catering to the pharmaceutical needs throughout Europe, Japan, and North America.

Why choose Adragos?

An integrated network, from initial product development and testing to scaling up to commercial production, we are your end-to-end partner in driving excellence.

Full CDMO Spectrum

Our offerings include full value chain from development to trial supply, scale-up, and commercial manufacturing.

Customer Centricity

Elevating the customer experience through dedicated commitment to meeting clients’ needs.

Global Presence

With an established presence in key pharmaceutical markets including the U.S., EU, and Japan, our five strategically located facilities deliver global reach with local expertise.


Data is crucial! We commit to a data-driven strategy to guarantee our services align perfectly with demands.

Our Team

Welcome to our team, where the vision of the Board, the leadership of the Management team and the dedication of the operational staff come together. We are not just colleagues, we are the Adragos family dedicated to making a difference.

  • Management
  • Board of Directors
  • Our Team

Our Management

Our leadership team has a long-standing and impressive track record in the pharmaceutical industry and CDMOs, demonstrating expertise and experience.

Our Team

Meet the dynamic individuals behind our success. Each member brings unique skills and perspectives that shape our company culture and drive our vision.


We are dedicated to creating a better world where every life-changing medication embodies environmental and social responsibility.


We are dedicated to incorporating sustainable practices to minimize our environmental footprint.


We strive to provide a safe and supportive work environment.

Corporate Governance

We uphold transparency and commit to ethical business practices in every aspect of our operations.

Subscribe to our newsletter!

Get notified on our latest news.